Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01267227 · ClinicalTrials.gov registry record · Phase 2
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress
A Phase 2 study of Blood Pressure and Oxidative Stress, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT01267227 is a Phase 2 study of Blood Pressure and Oxidative Stress that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 80 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01267227, a Phase 2 study of Blood Pressure and Oxidative Stress, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Pterostilbene is one of several stilbenes found in certain berries, particularly blueberries, that have demonstrated pre-clinical benefit to cholesterol, blood pressure, and oxidative stress. The purpose of this study is to evaluate whether pterostilbene will help control cholesterol and blood pressure, as well as improve markers for oxidative stress in patients with dyslipidemia meeting inclusion criteria. The investigators also want to look at the safety of pterostilbene in these patients.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pterostilbene 50 mg twice daily
- DRUG Grape Extract
- DRUG Pterostilbene 125 mg twice daily
Study Locations (1)
Mississippi
- University of Mississippi Medical Center - Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01267227
The ClinicalTrials.gov registry entry for NCT01267227 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (72% lower). The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT01267227 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.
Frequently Asked Questions
What is clinical trial NCT01267227 about?
NCT01267227 is a clinical study titled "Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress". Pterostilbene is one of several stilbenes found in certain berries, particularly blueberries, that have demonstrated pre-clinical benefit to cholesterol, blood pressure, and oxidative stress. The purpose of this study is to evaluate whether pterostilbene will help control cholesterol and blood press...
What is the current status of trial NCT01267227?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2010-12. Estimated completion is 2012-02.
What conditions does trial NCT01267227 study?
This clinical trial studies the following conditions: Blood Pressure, Oxidative Stress, Hyperlipidemia.
What interventions are being tested in trial NCT01267227?
The interventions under investigation include: Placebo (DRUG), Pterostilbene 50 mg twice daily (DRUG), Grape Extract (DRUG), Pterostilbene 125 mg twice daily (DRUG).
Who is sponsoring clinical trial NCT01267227?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01267227 being conducted?
This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
RECRUITING · Phase 2
-
Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
COMPLETED · Phase 2
-
Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress
COMPLETED · Phase 2
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.